Sanofi-Aventis (France) to Further Cut Costs, Reduce Sales Force, CFO Contamine Says

Bloomberg -- Sanofi-Aventis SA, France’s biggest drugmaker, plans further expense reductions in areas such as marketing to offset lower revenue that’s resulting from health- care reforms in Europe.